Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Can lipitor be taken with blood pressure drugs?What is the difference between spiriva handihaler and respimat?How can i speed up vascepa's approval process?Does mealtime affect ezetimibe's efficacy?What is lipitor's chemical structure responsible for inhibition?
When can patients safely take darolutamide after a meal? Darolutamide, a medication used to treat prostate cancer, is a nonsteroidal antiandrogen [1]. Patients should wait for a recommended time after eating before taking the medication to minimize interactions and potential side effects. The recommended waiting time after eating is crucial to ensure optimal absorption of the medication. According to the manufacturer, patients should not take darolutamide on an empty stomach, as it can cause stomach upset [2]. However, the exact waiting time is not specifically outlined in the manufacturer's guidelines. Studies on food and darolutamide Researchers investigated the effect of food on the pharmacokinetics of darolutamide in healthy male participants and patients with metastatic castration-resistant prostate cancer. Results showed that administering darolutamide with food significantly reduces peak plasma concentrations (Cmax) and area under the concentration-time curve (AUC) compared with fasting conditions [3]. Implications for patient care The study findings highlight the importance of the waiting time between meals and taking darolutamide. However, a precise waiting time recommendation is not made available in the literature. To minimize variability in absorption, patients can be advised to wait for at least a few hours after a meal before taking the medication. References [1] Darolutamide - NDA 208456 - Food and Drug Administration (2020) [2] Xtandi (darolutamide) - Product Information [3] The effects of food on the pharmacokinetics of darolutamide in healthy volunteers - Clinical Cancer Research, 10.1158/1078-0432.CCR-06-1445 (2006) Cited sources: 1: Darolutamide - NDA 208456 - Food and Drug Administration 2: Xtandi (darolutamide) - Product Information 3: The effects of food on the pharmacokinetics of darolutamide in healthy volunteers - Clinical Cancer Research
Other Questions About After :